MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹14 Cr | ₹25 Cr | ₹17 Cr | ₹24 Cr | ₹14 Cr |
What is the latest Total Non-Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹24 Cr |
| Mar2021 | ₹14 Cr |
How is Total Non-Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | -42.77 | |
| Mar2024 | ₹25 Cr | 44.30 | |
| Mar2023 | ₹17 Cr | -28.52 | |
| Mar2022 | ₹24 Cr | 79.29 | |
| Mar2021 | ₹14 Cr | - | |
Compare Total Non-Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹410.0 Cr | -0.2% | -16.5% | -11.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,500.0 Cr | -0.7% | -5.2% | -8.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,386.7 Cr | -4.5% | -11.6% | -6.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,116.2 Cr | -6.8% | 5.7% | -8.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,026.0 Cr | -2.1% | -4.2% | -29% | Stock Analytics | |
| INDO US BIOTECH | ₹221.0 Cr | -3.8% | -11.8% | -53.3% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -0.2% |
-16.5% |
-11.8% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses